Redhill Biopharma
RDHL
#10585
Rank
โ‚ฌ3.5 M
Marketcap
0,69ย โ‚ฌ
Share price
-0.01%
Change (1 day)
-67.85%
Change (1 year)

EPS for Redhill Biopharma (RDHL)

EPS in 2023 (TTM): -705,09ย โ‚ฌ

According to Redhill Biopharma's latest financial reports the company's current EPS (TTM) is -599,48ย โ‚ฌ. In 2017 the company made an earnings per share (EPS) of -2.141ย โ‚ฌ a decrease over its 2016 EPS that were of -1.884ย โ‚ฌ.

EPS history for Redhill Biopharma from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-705,09ย โ‚ฌ
2017-2.141ย โ‚ฌ13.64%
2016-1.884ย โ‚ฌ9.12%
2015-1.727ย โ‚ฌ68.01%
2014-1.028ย โ‚ฌ-25.93%
2013-1.387ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
1,77ย โ‚ฌ-100.30%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
6,26ย โ‚ฌ-101.04%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
3,23ย โ‚ฌ-100.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
1,06ย โ‚ฌ-100.18%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
1,04ย โ‚ฌ-100.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel